Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioCryst begins phase 1 trial with BCX9250 for treatment of fibrodysplasia ossificans progressiva
BioCryst begins phase 1 trial with BCX9250 for treatment of fibrodysplasia ossificans progressiva. Photo: courtesy of fernando zhiminaicela from Pixabay/Pixabay.